Parkinson Disease Pathogenic Variants

Key Points

• The aim is to assess genotyping success of the NeuroBooster array and analyze pathogenic variant frequencies in Parkinson disease across different ancestries.
• Evaluated genotyping success rate of the NeuroBooster array
• Analyzed frequencies of pathogenic variants
• Included participants from diverse ancestry backgrounds
• Identified varying frequencies of pathogenic variants across different ancestries
• Showed successful genotyping with the NeuroBooster array
• Provided insights into the role of ancestry in Parkinson disease variant distribution